Title : Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition.

Pub. Date : 2009 Aug 15

PMID : 19679550






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Glycosides tumor protein p53 Homo sapiens
2 We report here that p53, in multiple lines of human cancer cells, is down-regulated by cardiac glycoside drugs digoxin and ouabain, potent inhibitors of Na(+)/K(+)-ATPase. Glycosides tumor protein p53 Homo sapiens
3 This is the first report that cardiac glycoside drugs, by initiating the Src/MAPK signaling pathways, reduce the p53 levels via inhibition of p53 protein synthesis. Glycosides tumor protein p53 Homo sapiens
4 This is the first report that cardiac glycoside drugs, by initiating the Src/MAPK signaling pathways, reduce the p53 levels via inhibition of p53 protein synthesis. Glycosides tumor protein p53 Homo sapiens